a public good project by the
Synthesis
Company
of California

© 2026

Martine Piccart | doi.page

0 works0 citations0 h-index

Martine Piccart

Université Libre de Bruxelles(BE)Institut Jules Bordet(BE)Breast International Group(BE)

Publications by Year

Research Areas

HER2/EGFR in Cancer Research, Breast Cancer Treatment Studies, Cancer Treatment and Pharmacology, Advanced Breast Cancer Therapies, Cancer Genomics and Diagnostics

Most-Cited Works

→ Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer(2005)5,074 cited
→ Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis(2014)4,585 cited
→ Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013(2013)3,672 cited
→ Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer(2011)2,803 cited
→ Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis(2006)2,125 cited
→ 3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)(2016)2,058 cited

→ 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer(2016)

2,013 cited

→ A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer(2003)1,824 cited

→ Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015(2015)1,820 cited

→ Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98(2013)1,636 cited